COREPHARMA FDA Approval ANDA 215566

ANDA 215566

COREPHARMA

FDA Drug Application

Application #215566

Application Sponsors

ANDA 215566COREPHARMA

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL3.75MG0CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM
002TABLET;ORAL7.5MG0CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM
003TABLET;ORAL15MG0CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-06-14STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215566
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.